356 related articles for article (PubMed ID: 10412869)
21. [Clinical, genetic and molecular studies on autosomal dominant polycystic kidney disease].
Torra R; Badenas C; Darnell A; Nicolau C; Volpini V; Revert L; Estivill X
Med Clin (Barc); 1998 Apr; 110(13):481-7. PubMed ID: 9611728
[TBL] [Abstract][Full Text] [Related]
22. Genotypes of autosomal dominant polycystic kidney disease in Japanese.
Mizoguchi M; Tamura T; Yamaki A; Higashihara E; Shimizu Y
J Hum Genet; 2002; 47(1):51-4. PubMed ID: 11829141
[TBL] [Abstract][Full Text] [Related]
23. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells.
Nauli SM; Alenghat FJ; Luo Y; Williams E; Vassilev P; Li X; Elia AE; Lu W; Brown EM; Quinn SJ; Ingber DE; Zhou J
Nat Genet; 2003 Feb; 33(2):129-37. PubMed ID: 12514735
[TBL] [Abstract][Full Text] [Related]
24. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents.
Hanaoka K; Qian F; Boletta A; Bhunia AK; Piontek K; Tsiokas L; Sukhatme VP; Guggino WB; Germino GG
Nature; 2000 Dec 21-28; 408(6815):990-4. PubMed ID: 11140688
[TBL] [Abstract][Full Text] [Related]
25. Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue.
Ong AC; Ward CJ; Butler RJ; Biddolph S; Bowker C; Torra R; Pei Y; Harris PC
Am J Pathol; 1999 Jun; 154(6):1721-9. PubMed ID: 10362797
[TBL] [Abstract][Full Text] [Related]
26. Molecular basis of autosomal dominant polycystic kidney disease.
Al-Bhalal L; Akhtar M
Adv Anat Pathol; 2005 May; 12(3):126-33. PubMed ID: 15900113
[TBL] [Abstract][Full Text] [Related]
27. Polycystic kidney disease--the ciliary connection.
Ong AC; Wheatley DN
Lancet; 2003 Mar; 361(9359):774-6. PubMed ID: 12620752
[TBL] [Abstract][Full Text] [Related]
28. Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease.
Shao L; El-Jouni W; Kong F; Ramesh J; Kumar RS; Shen X; Ren J; Devendra S; Dorschel A; Wu M; Barrera I; Tabari A; Hu K; Haque N; Yambayev I; Li S; Kumar A; Behera TR; McDonough G; Furuichi M; Xifaras M; Lu T; Alhayaza RM; Miyabayashi K; Fan Q; Ajay AK; Zhou J
Kidney Int; 2020 Nov; 98(5):1225-1241. PubMed ID: 32610050
[TBL] [Abstract][Full Text] [Related]
29. The pathogenesis of autosomal dominant polycystic kidney disease: an update.
Somlo S; Markowitz GS
Curr Opin Nephrol Hypertens; 2000 Jul; 9(4):385-94. PubMed ID: 10926175
[TBL] [Abstract][Full Text] [Related]
30. Common regulatory elements in the polycystic kidney disease 1 and 2 promoter regions.
Lantinga-van Leeuwen IS; Leonhard WN; Dauwerse H; Baelde HJ; van Oost BA; Breuning MH; Peters DJ
Eur J Hum Genet; 2005 May; 13(5):649-59. PubMed ID: 15770226
[TBL] [Abstract][Full Text] [Related]
31. Polycystins, calcium signaling, and human diseases.
Delmas P; Padilla F; Osorio N; Coste B; Raoux M; Crest M
Biochem Biophys Res Commun; 2004 Oct; 322(4):1374-83. PubMed ID: 15336986
[TBL] [Abstract][Full Text] [Related]
32. Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients.
Torra R; Badenas C; Pérez-Oller L; Luis J; Millán S; Nicolau C; Oppenheimer F; Milà M; Darnell A
Am J Kidney Dis; 2000 Oct; 36(4):728-34. PubMed ID: 11007674
[TBL] [Abstract][Full Text] [Related]
33. Novel PKD1 and PKD2 mutations in Taiwanese patients with autosomal dominant polycystic kidney disease.
Chang MY; Chen HM; Jenq CC; Lee SY; Chen YM; Tian YC; Chen YC; Hung CC; Fang JT; Yang CW; Wu-Chou YH
J Hum Genet; 2013 Nov; 58(11):720-7. PubMed ID: 23985799
[TBL] [Abstract][Full Text] [Related]
34. The polycystins: a novel class of membrane-associated proteins involved in renal cystic disease.
Sandford R; Mulroy S; Foggensteiner L
Cell Mol Life Sci; 1999 Nov; 56(7-8):567-79. PubMed ID: 11212307
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetics of polycystic kidney disease.
Calvet JP
J Nephrol; 1998; 11(1):24-34. PubMed ID: 9561482
[TBL] [Abstract][Full Text] [Related]
36. Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease.
Wu G; Tian X; Nishimura S; Markowitz GS; D'Agati V; Park JH; Yao L; Li L; Geng L; Zhao H; Edelmann W; Somlo S
Hum Mol Genet; 2002 Aug; 11(16):1845-54. PubMed ID: 12140187
[TBL] [Abstract][Full Text] [Related]
37. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.
Zhang C; Balbo B; Ma M; Zhao J; Tian X; Kluger Y; Somlo S
J Am Soc Nephrol; 2021 Jan; 32(1):41-51. PubMed ID: 33046531
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetics and pathogenesis of autosomal dominant polycystic kidney disease.
Arnaout MA
Annu Rev Med; 2001; 52():93-123. PubMed ID: 11160770
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular Involvement in Patients with Autosomal Dominant Polycystic Kidney Disease: A Review.
Pietrzak-Nowacka M; Safranow K; Płońska-Gościniak E; Nowacki A; Późniak P; Gutowski P; Ciechanowski K
Kidney Blood Press Res; 2024; 49(1):9-19. PubMed ID: 38096797
[TBL] [Abstract][Full Text] [Related]
40. Association of PKD2 (polycystin 2) mutations with left-right laterality defects.
Bataille S; Demoulin N; Devuyst O; Audrézet MP; Dahan K; Godin M; Fontès M; Pirson Y; Burtey S
Am J Kidney Dis; 2011 Sep; 58(3):456-60. PubMed ID: 21719175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
